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a  b  s  t  r  a  c  t
We  report  a  case  of  eosinophilic  endomyocarditis  caused  by eosinophilia  due  to  dobutamine  allergy
and  successfully  treated  by  a short-term  and  medium-dose  steroid  administration.  Serial  endomyocar-
dial  biopsies  were  useful  for  early  diagnosis  and  evaluation  of the  effect  of  the  treatment.  Eosinophilic
endomyocarditis  due  to dobutamine  allergy  is a rare  entity;  however,  because  of  the  high utilization
rate  of  dobutamine  in  patients  with  low  output  heart  failure,  it is  important  to  recognize  that  additional
deterioration  of cardiac  function  caused  by eosinophilic  endomyocarditis  makes  prognosis  poor  and  earlyosinophilia
obutamine
iopsy
rug-induced lymphocyte stimulation test
intervention  is  necessary.
<Learning  objective:  Eosinophilic  endomyocarditis  due  to dobutamine  allergy  is  a  rare  entity;  however,
because  of  the  high  utilization  rate  of  dobutamine  in  patients  with  low  output  heart  failure,  it is important
to  recognize  that  additional  deterioration  of  cardiac  function  caused  by  eosinophilic  endomyocarditis
makes  their  prognosis  poor  and  early  intervention  is necessary.  Serial  endomyocardial  biopsies  were
useful  for  early  diagnosis  and  evaluation  of the  effect  of  the  treatment.>
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Dobutamine is widely used to stabilize patients compro-
ised with low output congestive heart failure. Eosinophilic
ndomyocarditis, an infrequent but potentially lethal complica-
ion of dobutamine use, has been reported in studies of either
ndomyocardial biopsy or autopsy [1–3]. We  here report a case
f eosinophilic endomyocarditis caused by eosinophilia due to
obutamine allergy, conﬁrmed by drug-induced lymphocyte stim-
lation test (DLST) and serial endomyocardial biopsies, which
as successfully treated by short-term and medium-dose steroid
dministration.
ase report
A 37-year-old woman with a 2-year history of chronic heart
ailure was referred to our hospital because of the worsening
f her symptoms. On admission, the echocardiogram revealed
eft ventricular dilatation, left ventricular end-diastolic dimension
LVDd) and end-systolic dimension (LVDs) were 61 and 46 mm,
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respectively, severely reduced systolic function, ejection fraction
(EF) was  21% and mild tricuspid insufﬁciency with a maximum
30 mmHg  gradient. The electrocardiogram showed tachycardia,
atrial ﬁbrillation, mild intraventricular conduction defect, and non-
speciﬁc ST segment elevation in precordial lead (Fig. 1). A chest
X-ray showed moderate cardiomegaly, pulmonary congestion, and
a small pleural effusion (Fig. 2). The laboratory data on admis-
sion are shown in Table 1. Serum brain natriuretic peptide (BNP)
level was 737 pg/mL. The patient was  initially treated with diuret-
ics, followed by a continuous infusion of dobutamine on day 11
in the hospital. Eight days after the onset of dobutamine infu-
sion, erythema, pruritus, and phlebitis appeared around the route
of the dobutamine infusion. The laboratory data showed a steady
increase in eosinophils in the blood during the treatment with
dobutamine (Fig. 3). Eosinophil count in the peripheral blood
was elevated to 911/L, 19.4% of total white blood cell count.
Serum eosinophil cationic protein (ECP) was  elevated to 37.4 g/L
where over 14.9 g/L is regarded as positive. Since dobutamine
was ﬁrstly considered a candidate cause of eosinophilia, the dobut-
amine infusion was gradually tapered and ﬁnally discontinued on
day 25. An anti-histamine drug was started simultaneously; how-
ever eosinophilia continued. On day 28, the patient was stabilized
except for eosinophilia. Because of her tattoo, cardiac magnetic
resonance imaging was  not performed. Cardiac catheterization
vier Ltd. All rights reserved.
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Fig. 1. Time course of the 
Table 1
Laboratory data on admission.
WBC 8800/L TP 6.4 g/dL
Neut 73.3% Alb 4.0 g/dL
Lymp 19.1% T-Bil 0.8 mg/dL
Eos 1.7% AST 22 IU/L
Mono 5.4% ALT 27 IU/L
Baso 0.5% -GTP 25 IU/L
RBC 452 × 103/L LDH 169 IU/L
Hb  14.3 g/dL ALP 211 IU/L
PLT  23.8 × 104/L Amy  34 IU/L
PT-INR 2.08 CK 46 IU/L
APTT 36 s BUN 18 mg/dL
AT  III 99% Cr 0.79 mg/dL
Fibrinogen 292 mg/dL UA 7.9 mg/dL
FDP 2 g/mL Na 138 mEq/L
D-dimer <0.5 g/mL K 4.3 mEq/L
FT4 1.5 ng/dL Cl 100 mEq/L
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ocarditis. There was  no remarkable change on electrocardiogram,TSH  1.96 IU/mL Ca 9.1 mg/dL
HbA1c 5.7% CRP 0.09 mg/dL
emonstrated a pulmonary artery pressure of 25/8 (14) mmHg,
ardiac index of 2.18 L/min/m2, pulmonary capillary wedge pres-
ure of 7 mmHg, and left ventricular pressure of 97/edp12 mmHg.
here was left ventricular enlargement and global systolic dys-
unction at an EF of 33% and nonobstructive coronary artery.
n endomyocardial biopsy from the septum of the right ventri-
le was performed to diagnose the etiology of left ventricular
ysfunction and revealed mild interstitial ﬁbrosis, hypertrophy,
Fig. 2. Time course of electrocardiograms.
and disarrangement of residual myocytes compatible with dilated
cardiomyopathy (DCM) and, furthermore, the presence of
eosinophilic endomyocarditis by chance. Extensive eosinophilic
inﬁltrate was recognized mainly in the subendocardial interstitium
and to a lesser extent in the myocardial tissue. Major basic protein
(MBP) was  positive in the eosinophils and the area of extracellu-
lar edema as was  demonstrated by immunohistochemistry (Fig. 4a
and b). DLST for dobutamine expressed as a stimulatory index
where over 180% is considered positive, yielded values of 758%.
These ﬁndings suggested that eosinophilia due to hypersensitivity
to dobutamine may  cause eosinophilic endomyocarditis. On day
42, in spite of eosinophilic endomyocarditis, follow-up echocar-
diogram revealed slightly improved left ventricular dimensions
(LVDd/LVDs = 58/43 mm),  systolic function (EF = 39%), and immea-
surable tricuspid insufﬁciency. Oral administration of 20 mg  per
day prednisolone was initiated on day 45 for both eosinophilia
and eosinophilic endomyocarditis, and prednisolone was gradually
tapered and stopped within 12 days. Eosinophil count in the blood
had returned to normal values by day 56. The second endomyocar-
dial biopsy on day 60 revealed very few scattered eosinophils and
no extracellular deposition of MBP  (Fig. 4c and d). Fortunately, our
patient did not show additional deterioration of cardiac function
on echocardiogram during eosinophilia and eosinophilic endomy-cardiomegaly and pulmonary congestion on chest X-ray were
improved and serum BNP level promptly decreased and showed
no signiﬁcant increase during eosinophilia and eosinophilic
the chest X-rays.
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Fig. 3. Time courses of peripheral blood eosinophilic cell count (blue squares and line), eosinophilic cationic protein (red triangles), and brain natriuretic peptide (green
c l eosin
i ader i
e
t
i
e
f
4
F
(
e
dircle)  relative to drug administration. Normal eosinophil count is <500/L. Norma
s  <18.4 pg/mL. (For interpretation of references to color in this ﬁgure legend, the re
ndomyocarditis (Figs. 1–3).  She was discharged with adminis-
ration of a beta blocker and an angiotensin-converting enzyme
nhibitor on day 67 and has since been doing well. Follow-up
chocardiogram after two months of leaving hospital revealed
urther improvement, LVDd/LVDs was 58/40 mm  and EF was
3%.
ig. 4. Photomicrographs of serial endomyocardial biopsies. (a) The ﬁrst biopsy on 
hemataoxylin and eosin). (b) Immunohistochemistry of major basic protein (MBP) is 
osinopilic endomyocarditis with few eosinophils is shown (hemataoxylin and eosin). (d)
 is 50 m.ophilic cationic protein value is <14.9 g/L. Normal brain natriuretic peptide level
s referred to the web version of this article.)
DiscussionOur patient was  diagnosed as having idiopathic DCM on the
basis of a number of investigations, including biopsy. Neither the
eosinophilia nor the eosinophilic endomyocarditis was considered
to be a cause of left ventricular dysfunction in our patient because
day 28 showed intensive eosinophilic inﬁltrate in subendocardial interstitium
positive mainly in endocardium. (c) The second biopsy on day 60; regression of
 No deposition of MBP  conﬁrmed by immunohistochemistry. The bar in a, b, c, and
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eft ventricular dilatation and severely reduced ejection fraction
ere found prior to the appearance of eosinophilia; in addition the
eriod from appearance of eosinophilia to ﬁrst biopsy was too short
or eosinophilia to be a cause of left ventricular dysfunction.
Eosinophilia in our patient was considered to be an allergic
eaction to dobutamine because DLST for dobutamine was posi-
ive, eosinophil count remains in the normal range after cessation
f dobutamine regardless of the continuation of other drugs and
LST for amiodarone and carvedilol were negative (Fig. 3). Aller-
ic reaction to dobutamine is reported to be not dose related [1].
his may  explain why the eosinophil count in our patient increased
hile dobutamine was being tapered. Generally eosinophilia was
bserved only during dobutamine infusion, although eosinophilia
n our patient continued after cessation of dobutamine infusion.
pear reported a case of eosinophilia that was noted after cessation
f short-term dobutamine infusion [4].  Therefore, the association
etween dobutamine allergy and the duration of eosinophilia has
ot been understood clearly to date.
Eosinophilia due to dobutamine allergy is often associated with
ong-term infusions, such as those employed over a period of
 month as pharmacologic bridges to heart transplantation [4].
n the other hand, short-term dobutamine infusion has been
eported to be associated with a local reaction at the site of dobut-
mine infusion accompanied by eosinophilia. Such dermal lesions
ave been considered to represent hypersensitivity to dobutamine
4–6]. Therefore, eosinophils play a role in immediate and delayed
ypersensitivity reactions, and both mechanisms may  participate
n eosinophilic endomyocarditis due to dobutamine allergy [3].
ndomyocardial injury may  be provoked by eosinophil degranula-
ion and deposition of eosinophilic granules such as MBP  and ECP,
uggesting that serum ECP, a marker of activated eosinophil granu-
ocytes, may  be helpful in diagnosing eosinophilic endomyocarditis
1,2,7,8]. Eosinophilic endomyocarditis should be suspected when
eripheral blood eosinophilia is present, or the eosinophil count is
ncreased by at least two-fold [1].  Endomyocardial biopsy is nec-
ssary to make a ﬁrm diagnosis and is warranted when a patient
ith eosinophilia shows signs of heart failure [3];  and exam-
nation of biopsy samples using both electron microscopy and
mmunohistochemistry with speciﬁc antibodies, are recommended
o detect eosinophil granule components [9].  DLST, a measure
f proliferation of T cells in response to a drug in vitro, is the
ost generally used in vitro test for the detection of the causative
rug in drug-induced allergies. However there has been no report
f DLST in dobutamine-associated eosinophilia, and further stud-
es are necessary to evaluate the efﬁcacy of DLST in relation to
he side effects of dobutamine. Eosinophil counts and concomi-
ant symptoms of drug allergy such as erythema and pruritus
ust be closely monitored. Furthermore, patients with clinically
uspected dobutamine-related eosinophilia should be considered
or treatment with alternative inotropic drugs. When patients do
ot respond to cessation of dobutamine or switching to another
[
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inotropic drug in a few days, steroid therapy should be considered.
Although previous studies have documented dramatic responses to
steroid therapy in some patients with eosinophilic endomyocardi-
tis, the appropriate dose of steroid for eosinophilic endomyocarditis
induced by drug allergy has not been determined to date. A medium
dose of steroid may  be effective in the early stage of drug allergy as
in our patient, although steroid pulse therapy is generally recom-
mended for hypereosinophilic syndrome [2].
We  have reported a case of eosinophilic endomyocarditis caused
by eosinophilia due to dobutamine allergy and its successful treat-
ment with a short-term and medium-dose steroid administration.
Since we  usually use dobutamine in patients with acute or chronic
decompensated heart failure, it is important to recognize the pos-
sibility of eosinophilic endomyocarditis due to dobutamine allergy
despite its rare occurrence. Because additional worsening of cardiac
function caused by endomyocarditis results in poor clinical out-
comes, serial eosinophil count examinations should be considered
and a decision on early steroid intervention is necessary. DLST may
be useful for early diagnosis of dobutamine allergy. Serial endomy-
ocardial biopsy and serum ECP measurement are also useful for
diagnosis and evaluation of the effect of the treatment.
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